https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-21 / World J. Gastroenterol. 2006 Jan;12(3):473-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-21 / World J. Gastroenterol. 2006 Jan;12(3):473-82006-01-21 00:00:002019-02-15 08:38:17Heat-shocked tumor cell lysate-pulsed dendritic cells induce effective anti-tumor immune response in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-18 / Immunobiology 2006;211(1-2):29-36
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-18 / Immunobiology 2006;211(1-2):29-362006-01-18 00:00:002019-02-15 08:44:42Immunization with antigen-pulsed dendritic cells significantly improves the immune response to weak self-antigens
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-18 / Vaccine 2006 Feb;24(7):887-96
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-18 / Vaccine 2006 Feb;24(7):887-962006-01-18 00:00:002019-02-15 08:37:42Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-17 / Ann. Oncol. 2006 Apr;17(4):563-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-17 / Ann. Oncol. 2006 Apr;17(4):563-702006-01-17 00:00:002019-02-15 09:19:51Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-09 / Proc. Natl. Acad. Sci. U.S.A. 2006 Jan;103(3):738-43
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-09 / Proc. Natl. Acad. Sci. U.S.A. 2006 Jan;103(3):738-432006-01-09 00:00:002019-02-15 09:15:17Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-05 / Breast Cancer Res. 2006;8(1):101
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-05 / Breast Cancer Res. 2006;8(1):1012006-01-05 00:00:002019-02-15 08:44:41Dendritic cell defects in patients with cancer: mechanisms and significance
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-01 / J. Immunother. 2006 Jan-Feb;29(1):67-77
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-01 / J. Immunother. 2006 Jan-Feb;29(1):67-772006-01-01 00:00:002006-01-01 00:00:00Quick generation of fully mature dendritic cells from monocytes with OK432, low-dose prostanoid, and interferon-alpha as potent immune enhancers
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-01 / Leuk. Lymphoma 2006 Jan;47(1):29-37
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-01 / Leuk. Lymphoma 2006 Jan;47(1):29-372006-01-01 00:00:002019-02-15 08:51:02Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-01 / Cytotherapy 2006;8(3):277-89
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-01 / Cytotherapy 2006;8(3):277-892006-01-01 00:00:002019-02-15 08:51:01Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-01 / Curr. Pharm. Des. 2006;12(7):807-17
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-01 / Curr. Pharm. Des. 2006;12(7):807-172006-01-01 00:00:002019-02-15 09:24:18Immunotherapy for prostate cancer
